ArticleMolecular cancer therapeutics2011

Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924.

Xiaonan Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.